Last Updated: May 20, 2026

Claims for Patent: 9,040,050

✉ Email this page to a colleague

Summary for Patent: 9,040,050

Title:	Combination treatment of CD38-expressing tumors
Abstract:	The invention relates to novel method for the treatment of cancer using a combination therapy comprising an antibody that binds CD38, a corticosteroid and a non-corticosteroid chemotherapeutic agent.
Inventor(s):	Van De Winkel Jan, Parren Paul, Graus Yvo, Oprins Judith, De Weers Michel, Van Vugt Martine, Baadsgaard Ole, Lisby Steen
Assignee:	GENMAB A/S
Application Number:	US12442808

Details for Patent 9,040,050

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Janssen Biotech, Inc.	DARZALEX	daratumumab	Injection	761036	November 16, 2015	9,040,050	2027-09-26
Janssen Biotech, Inc.	DARZALEX FASPRO	daratumumab and hyaluronidase-fihj	Injection	761145	May 01, 2020	9,040,050	2027-09-26
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 9,040,050

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2008037257	⤷ Start Trial
United States of America	2024165226	⤷ Start Trial
United States of America	2020114000	⤷ Start Trial
United States of America	2015231235	⤷ Start Trial
United States of America	2010092489	⤷ Start Trial
Turkey	201910145	⤷ Start Trial
Slovenia	2081595	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.